Business model
LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine
LakeShore Biopharma Co., Ltd.
Ashling Partners Wins Celonis Partner of the Year at Celosphere 2024
Ashling Partners